Search research articles
Contact Us
Filters
Showing results (131-140 of 273) with videos related to
Page
of 28
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 9, 2013
Busulfan dose intensity and outcomes in reduced-intensity allogeneic peripheral blood stem cell transplantation for myelodysplastic syndrome or acute myeloid leukemia
Yi-Bin Chen, Erin Coughlin, Kevin F Kennedy, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 22, 2010
Iron overload in patients with acute leukemia or MDS undergoing myeloablative stem cell transplantation
Philippe Armand, Haesook T Kim, Joanna Rhodes, et al.
Blood
|
July 18, 2013
Rituximab prophylaxis prevents corticosteroid-requiring chronic GVHD after allogeneic peripheral blood stem cell transplantation: results of a phase 2 trial
Corey Cutler, Haesook T Kim, Bhavjot Bindra, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 18, 2008
Allogeneic transplantation with reduced-intensity conditioning for Hodgkin and non-Hodgkin lymphoma: importance of histology for outcome
Philippe Armand, Haesook T Kim, Vincent T Ho, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 10, 2015
A Bortezomib-Based Regimen Offers Promising Survival and Graft-versus-Host Disease Prophylaxis in Myeloablative HLA-Mismatched and Unrelated Donor Transplantation: A Phase II Trial
John Koreth, Haesook T Kim, Paulina B Lange, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 28, 2014
Post-transplantation B cell activating factor and B cell recovery before onset of chronic graft-versus-host disease
Caron A Jacobson, Lixian Sun, Haesook T Kim, et al.
Blood Advances
|
March 3, 2025
Nivolumab plus relatlimab in patients with relapsed or progressed B-cell malignancies in RELATIVITY-022
Ajay K Gopal, Philippe Armand, Sattva S Neelapu, et al.
Bone Marrow Transplantation
|
October 12, 2020
Correction: Phase II trial of natalizumab with corticosteroids as initial treatment of gastrointestinal acute graft-versus-host disease
Natasha Kekre, Haesook T Kim, Julia Hofer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 13, 2008
Improved survival in lymphoma patients receiving sirolimus for graft-versus-host disease prophylaxis after allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning
Philippe Armand, Supriya Gannamaneni, Haesook T Kim, et al.
Annals of Internal Medicine
|
July 23, 2014
Antiretroviral-free HIV-1 remission and viral rebound after allogeneic stem cell transplantation: report of 2 cases
Timothy J Henrich, Emily Hanhauser, Francisco M Marty, et al.
Page
of 28
Search research articles
Search
Showing results (131-140 of 273) with videos related to
Sort By:
Page
of 28
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 9, 2013
Busulfan dose intensity and outcomes in reduced-intensity allogeneic peripheral blood stem cell transplantation for myelodysplastic syndrome or acute myeloid leukemia
Yi-Bin Chen, Erin Coughlin, Kevin F Kennedy, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 22, 2010
Iron overload in patients with acute leukemia or MDS undergoing myeloablative stem cell transplantation
Philippe Armand, Haesook T Kim, Joanna Rhodes, et al.
Blood
|
July 18, 2013
Rituximab prophylaxis prevents corticosteroid-requiring chronic GVHD after allogeneic peripheral blood stem cell transplantation: results of a phase 2 trial
Corey Cutler, Haesook T Kim, Bhavjot Bindra, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 18, 2008
Allogeneic transplantation with reduced-intensity conditioning for Hodgkin and non-Hodgkin lymphoma: importance of histology for outcome
Philippe Armand, Haesook T Kim, Vincent T Ho, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 10, 2015
A Bortezomib-Based Regimen Offers Promising Survival and Graft-versus-Host Disease Prophylaxis in Myeloablative HLA-Mismatched and Unrelated Donor Transplantation: A Phase II Trial
John Koreth, Haesook T Kim, Paulina B Lange, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 28, 2014
Post-transplantation B cell activating factor and B cell recovery before onset of chronic graft-versus-host disease
Caron A Jacobson, Lixian Sun, Haesook T Kim, et al.
Blood Advances
|
March 3, 2025
Nivolumab plus relatlimab in patients with relapsed or progressed B-cell malignancies in RELATIVITY-022
Ajay K Gopal, Philippe Armand, Sattva S Neelapu, et al.
Bone Marrow Transplantation
|
October 12, 2020
Correction: Phase II trial of natalizumab with corticosteroids as initial treatment of gastrointestinal acute graft-versus-host disease
Natasha Kekre, Haesook T Kim, Julia Hofer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 13, 2008
Improved survival in lymphoma patients receiving sirolimus for graft-versus-host disease prophylaxis after allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning
Philippe Armand, Supriya Gannamaneni, Haesook T Kim, et al.
Annals of Internal Medicine
|
July 23, 2014
Antiretroviral-free HIV-1 remission and viral rebound after allogeneic stem cell transplantation: report of 2 cases
Timothy J Henrich, Emily Hanhauser, Francisco M Marty, et al.
Page
of 28